Clinical Trials Directory

Trials / Completed

CompletedNCT03612258

Brain Mechanisms of Juvenile Fibromyalgia

Brain Mechanisms of Altered Sensory Perception and Self-Referential Processing in Juvenile Fibromyalgia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
153 (actual)
Sponsor
Children's Hospital Medical Center, Cincinnati · Academic / Other
Sex
Female
Age
13 Years – 17 Years
Healthy volunteers
Accepted

Summary

This study evaluates whether differences exist between adolescent females with juvenile-onset fibromyalgia and healthy controls in processing of pain and emotion at the neural level as assessed by functional magnetic resonance imaging (fMRI). The study includes a longitudinal component to evaluate changes in neural processing of pain and emotion before and after different treatment strategies.

Detailed description

Juvenile-onset fibromyalgia (JFM) is a chronic, widespread pain condition that primarily affects females. Previous work has shown increased sensitivity to painful and non-painful sensory stimuli in adults with fibromyalgia, as well as brain processing abnormalities associated with these stimuli. These abnormalities in adults are highly predictive of fibromyalgia status (as opposed to healthy status) in adults. Although JFM has some similar symptoms and features to fibromyalgia in adults, the neural mechanisms of JFM may be partially different, given the moment of sharp brain development characterising JFM. fMRI scans will be completed before and after different treatments for JFM (e.g. neuromuscular training + cognitive behavioral therapy, graded aerobic exercise) to investigate the effects of treatment on brain measures related to pain, fatigue and emotion processing.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTFunctional Magnetic Resonance ImagingFunctional Magnetic Resonance Imaging scans will be completed to assess neural responses to painful, non-painful sensory, and emotion-eliciting stimuli.

Timeline

Start date
2018-02-28
Primary completion
2024-07-31
Completion
2024-07-31
First posted
2018-08-02
Last updated
2025-01-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03612258. Inclusion in this directory is not an endorsement.